This audit aimed to measure compliance with DHSSPS guideline on Paediatric Parenteral Fluid Therapy (September 2007) and NPSA Patient safety alert 22. This was done by:
Documentation of IV fluids and laboratory monitoring in two key conditions in hospitalised children and young people at high risk for hyponatraemia (not resuscitation) – appendicitis and bronchiolitis (including ages greater than one month up until 15 years and 364 days)
Documentation of any adverse clinical outcomes (clinical deterioration or electrolyte abnormality) in any patient associated with: (a) Correct use of guideline directed IV fluids (b) Incorrect use of guideline directed IV fluids
To provide essential data required for subsequent review/revision of the new regional guideline.